Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$519M |
| 2 |
Netflix
NFLX
|
+$448M |
| 3 |
Qualcomm
QCOM
|
+$280M |
| 4 |
Microsoft
MSFT
|
+$252M |
| 5 |
Broadcom
AVGO
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$453M |
| 2 |
ExxonMobil
XOM
|
+$234M |
| 3 |
GMS
GMS Inc
GMS
|
+$217M |
| 4 |
SKX
Skechers
SKX
|
+$201M |
| 5 |
Capital One
COF
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 17.99% |
| 3 | Industrials | 12.15% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Healthcare | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Inovio Pharmaceuticals
INO
$79.8M
| $89.1K | ﹤0.01% |
37,991
-2,465
| -6% | -$4.72K |
|
3202
Palladyne AI
PDYN
$233M
| $88.1K | ﹤0.01% |
10,257
| – | – |
|
3203
Tandy Leather Factory
TLF
$19.5M
| $85.8K | ﹤0.01% |
28,305
+1,360
| +5% | +$4.41K |
|
3204
Sypris Solutions
SYPR
$43.7M
| $84.2K | ﹤0.01% |
39,514
-1,845
| -4% | -$3.77K |
|
3205
Sono-Tek
SOTK
$81.6M
| $84.1K | ﹤0.01% |
18,773
+4,305
| +30% | +$15.6K |
|
|
WHWK
3206
Whitehawk Therapeutics
WHWK
$183M
| $83.8K | ﹤0.01% |
44,115
-26,634
| -38% | -$49K |
|
3207
MediciNova
MNOV
$65M
| $83.4K | ﹤0.01% |
66,215
| – | – |
|
|
MURA
3208
DELISTED
Mural Oncology
MURA
| $82.4K | ﹤0.01% |
39,822
-5,782
| -13% | -$12.4K |
|
|
ALMS
3209
Alumis Inc
ALMS
$3.57B
| $81.9K | ﹤0.01% |
20,516
-1,024
| -5% | -$4.22K |
|
3210
Pyxis Oncology
PYXS
$165M
| $81.1K | ﹤0.01% |
36,516
| – | – |
|
3211
Stabilis Solutions
SLNG
$85.5M
| $80.8K | ﹤0.01% |
18,523
+2,207
| +14% | +$9.7K |
|
3212
Ideal Power
IPWR
$65.4M
| $79.9K | ﹤0.01% |
15,889
| – | – |
|
3213
MoonLake Immunotherapeutics
MLTX
$1.59B
| $78.9K | ﹤0.01% |
11,002
-41,717
| -79% | -$2.17M |
|
|
GENVR
3214
Gen Digital Inc Contingent Value Rights
GENVR
| $78.4K | ﹤0.01% |
11,245
| – | – |
|
3215
Perfect Corp
PERF
$197M
| $76.2K | ﹤0.01% |
40,477
+15,754
| +64% | +$32.9K |
|
3216
Braskem
BAK
$980M
| $75.2K | ﹤0.01% |
30,622
-15,128
| -33% | -$48.5K |
|
3217
Acumen Pharmaceuticals
ABOS
$154M
| $74.4K | ﹤0.01% |
43,524
| – | – |
|
|
ELVA
3218
Electrovaya
ELVA
$412M
| $73.5K | ﹤0.01% |
+12,324
| New | +$62.5K |
|
3219
TechPrecision Corp
TPCS
$45.7M
| $73.2K | ﹤0.01% |
13,760
-1,935
| -12% | -$9.29K |
|
3220
Cellectar Biosciences
CLRB
$19.3M
| $73K | ﹤0.01% |
+13,033
| New | +$64.6K |
|
3221
Blink Charging
BLNK
$75.2M
| $70.2K | ﹤0.01% |
42,819
| – | – |
|
3222
Barnwell Industries
BRN
$15.4M
| $69.8K | ﹤0.01% |
53,704
| – | – |
|
3223
Alpha Teknova
TKNO
$266M
| $68.8K | ﹤0.01% |
11,317
| – | – |
|
3224
Sera Prognostics
SERA
$80.3M
| $68.6K | ﹤0.01% |
22,424
| – | – |
|
|
NOTV
3225
DELISTED
Inotiv
NOTV
| $67.7K | ﹤0.01% |
46,796
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Dimensional Fund Advisors held 3,356 positions worth $466B, up 7.9% from $432B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q3 2025 filing shows 84 new, 1,582 increased, 1,511 reduced and 85 closed positions. Its largest new stake was Qiagen: 1,300,037 shares worth $58.1M. The largest sale was Hess, an estimated $453M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q3 2025 buy was Qiagen: 1,300,037 shares worth $58.1M.
- Dimensional Fund Advisors added most to Chevron in Q3 2025, an estimated $519M increase.
- Dimensional Fund Advisors's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $234M.
- Dimensional Fund Advisors fully exited Hess in Q3 2025, selling an estimated $453M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $466B portfolio in Q3 2025.
- Dimensional Fund Advisors opened 84 new positions and closed 85 in Q3 2025.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $466B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.